Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of the ProMRI Study (Phase B) is to demonstrate the clinical safety of the ProMRI Pacemaker System when used under specific MRI conditions without scan exclusion zone.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pacemaker Therapy | Patients with a ProMRI Pacemaker System |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Patients with a ProMRI Pacemaker System | Device | Bradycardia Slow Heart Beat |
| |
| Measure | Description | Time Frame |
|---|---|---|
| MRI and Pacing System Related Serious Adverse Device Effect (SADE) Free Rate | 1 Month Post-MRI | |
| Percentage of Participants Free of Atrial Pacing Threshold Rise | Evaluate the percentage of atrial pacing leads with a pacing threshold increaess between the Pre-MRI and one-month post-MRI follow-up. | Between Pre-MRI and 1 Month Post-MRI |
| Percentage of Participants Free of Ventricular Pacing Threshold Rise | Evaluate the percentage of ventricular pacing leads with a pacing threshold increase between the Pre-MRI and one-month post-MRI follow-up. | Between Pre-MRI and 1 Month Post-MRI |
| Percentage of Participants Free of P-wave Sensing Attenuation | Evaluate the percentage of subjects who experience P-wave attenuation between the pre-MRI and one-month post-MRI follow-up. | Between Pre-MRI and 1 Month Post-MRI |
| Percentage of Participants Free of R-wave Sensing Attenuation | Evaluate the percentage of subjects who experience R-wave attenuation between the pre-MRI and one-month post-MRI follow-up. | Between Pre-MRI and 1 Month Post-MRI |
Not provided
Not provided
Inclusion Criteria:
The following initial inclusion criteria must be met for a subject to be enrolled and considered for the MRI-procedure:
At the pre-MRI procedure, the following procedure-related criteria must be met for the subject to undergo the MRI scan:
Absence of phrenic nerve stimulation at 4.8V @ 1.0 ms
•|pacing threshold at Pre-MRI follow-up - pacing threshold at baseline| ≤ 0.5 V
All pacing thresholds are measureable and are ≤ 2.0 V @ 0.4 ms
The pacemaker system has been implanted for at least 6 weeks.
Subject did not have a pacemaker or lead explant, exchange or reposition in the previous 6 weeks.
All lead impedances are between 200 and 1500 ohm.
Battery status is at least 30% of capacity
Exclusion Criteria:
Enrolled in any other clinical study
For pacemaker systems that include an atrial lead, subjects with either
Life expectancy of less than three months
Pregnancy
Cardiac surgery expected in the next three months
Implanted with other medical devices that may interact with MRI, such as:
Not provided
Not provided
Not provided
The patients selected for participation should be from the investigators' general patient population according to the inclusion and exclusion criteria.
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Phoenix | Arizona | 85018 | United States | |||
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26409098 | Result | Bailey WM, Mazur A, McCotter C, Woodard PK, Rosenthal L, Johnson W, Mela T; ProMRI Study Investigators. Clinical safety of the ProMRI pacemaker system in patients subjected to thoracic spine and cardiac 1.5-T magnetic resonance imaging scanning conditions. Heart Rhythm. 2016 Feb;13(2):464-71. doi: 10.1016/j.hrthm.2015.09.021. Epub 2015 Sep 25. |
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Pacemaker Therapy | Patients with a ProMRI Pacemaker System Patients with a ProMRI Pacemaker System: Bradycardia Slow Heart Beat Magnetic Resonance Imaging (MRI) scan: MRI scan of heart/chest or thoracic spine. |
| Title | Milestones | Reasons Not Completed | |||||
|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Magnetic Resonance Imaging (MRI) scan |
| Other |
MRI scan of heart/chest or thoracic spine. |
|
| Scottsdale |
| Arizona |
| 85251 |
| United States |
| Concord | California | 94520 | United States |
| Newport Beach | California | 92663 | United States |
| Rancho Mirage | California | 92270 | United States |
| New Haven | Connecticut | 06510 | United States |
| Newark | Delaware | 19702-5438 | United States |
| Washington D.C. | District of Columbia | 20010 | United States |
| Valparaiso | Indiana | 46383 | United States |
| Iowa City | Iowa | 52242 | United States |
| Lafayette | Louisiana | 70503 | United States |
| Cumberland | Maryland | 21502 | United States |
| Boston | Massachusetts | 02114 | United States |
| Burlington | Massachusetts | 01805 | United States |
| Worcester | Massachusetts | 01655 | United States |
| Ann Arbor | Michigan | 48109 | United States |
| Ypsilanti | Michigan | 48197 | United States |
| Kansas City | Missouri | 64132 | United States |
| St Louis | Missouri | 63110 | United States |
| Flushing | New York | 11355 | United States |
| New York | New York | 10016 | United States |
| The Bronx | New York | 10463 | United States |
| Winston-Salem | North Carolina | 27157 | United States |
| Toledo | Ohio | 43615 | United States |
| Salem | Oregon | 97301 | United States |
| Newtown | Pennsylvania | 18940 | United States |
| Greenville | South Carolina | 29605 | United States |
| Greenville | South Carolina | 29607 | United States |
| Amarillo | Texas | 79106 | United States |
| Mechanicsville | Virginia | 23116 | United States |
| Virginia Beach | Virginia | 23454 | United States |
| Spokane | Washington | 99204 | United States |
| COMPLETED |
|
| NOT COMPLETED |
|
|
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Pacemaker Therapy | Patients with a ProMRI Pacemaker System Patients with a ProMRI Pacemaker System: Bradycardia Slow Heart Beat Magnetic Resonance Imaging (MRI) scan: MRI scan of heart/chest or thoracic spine. |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean | Standard Deviation | years |
| |||||||||||||||||
| Sex: Female, Male | Count of Participants | Participants |
|
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | MRI and Pacing System Related Serious Adverse Device Effect (SADE) Free Rate | Posted | Number | 95% Confidence Interval | percentage of participants | 1 Month Post-MRI |
|
|
| |||||||||||||||||||||||||||
| Primary | Percentage of Participants Free of Atrial Pacing Threshold Rise | Evaluate the percentage of atrial pacing leads with a pacing threshold increaess between the Pre-MRI and one-month post-MRI follow-up. | Number of participants with an atrial lead and same atrial threshold polarity (either uni- or bi-polar) at pre-MRI and one-month post-MRI. | Posted | Number | 95% Confidence Interval | percentage of participants | Between Pre-MRI and 1 Month Post-MRI |
|
| ||||||||||||||||||||||||||
| Primary | Percentage of Participants Free of Ventricular Pacing Threshold Rise | Evaluate the percentage of ventricular pacing leads with a pacing threshold increase between the Pre-MRI and one-month post-MRI follow-up. | Number of participants with a ventricular lead and same ventricular threshold polarity (either uni- or bi-polar) at pre-MRI and one-month post-MRI. | Posted | Number | 95% Confidence Interval | percentage of participants | Between Pre-MRI and 1 Month Post-MRI |
|
| ||||||||||||||||||||||||||
| Primary | Percentage of Participants Free of P-wave Sensing Attenuation | Evaluate the percentage of subjects who experience P-wave attenuation between the pre-MRI and one-month post-MRI follow-up. | Number of participants with an atrial lead and same sensing polarity (either uni- or bi-polar) at pre-MRI and one-month post-MRI. | Posted | Number | 95% Confidence Interval | percentage of participants | Between Pre-MRI and 1 Month Post-MRI |
|
| ||||||||||||||||||||||||||
| Primary | Percentage of Participants Free of R-wave Sensing Attenuation | Evaluate the percentage of subjects who experience R-wave attenuation between the pre-MRI and one-month post-MRI follow-up. | Number of participants with a ventricular lead and same ventricular sensing polarity (either uni- or bi-polar) at pre-MRI and one-month post-MRI. | Posted | Number | 95% Confidence Interval | percentage of participants | Between Pre-MRI and 1 Month Post-MRI |
|
|
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Pacemaker Therapy | Patients with a ProMRI Pacemaker System Patients with a ProMRI Pacemaker System: Bradycardia Slow Heart Beat Magnetic Resonance Imaging (MRI) scan: MRI scan of heart/chest or thoracic spine. | 22 | 221 | 38 | 221 |
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| Angina | Cardiac disorders | Systematic Assessment |
| ||
| Arrhythmia | Cardiac disorders | Systematic Assessment |
| ||
| Cancer | General disorders | Systematic Assessment |
| ||
| Coronary Artery Disease | Cardiac disorders | Systematic Assessment |
| ||
| Gastrointestinal | Gastrointestinal disorders | Systematic Assessment |
| ||
| Infection | General disorders | Systematic Assessment |
| ||
| Medication Related | General disorders | Systematic Assessment |
| ||
| Musculoskeletal | Musculoskeletal and connective tissue disorders | Systematic Assessment |
| ||
| Peripheral Vascular Disease | Vascular disorders | Systematic Assessment |
| ||
| Syncope/Pre-Syncope | Cardiac disorders | Systematic Assessment |
| ||
| Worsening Chronic Heart Failure | Cardiac disorders | Systematic Assessment |
| ||
| General Disorders | General disorders | Systematic Assessment |
|
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| MRI Incidental Finding | General disorders | Systematic Assessment |
|
Principal Investigators agree to submit copies of any manuscript proposed for publication to Sponsor for review at least 30 days in advance of submission for publication or presentation. Sponsor may extend such review period for another 90 days to file patent applications or take other steps to protect its intellectual property interests, or to remove from the paper or presentation any language that is detrimental to Sponsor's intellectual property interests.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Clinical Studies Engineer | Biotronik, Inc. | 503-927-7230 | justin.michalski@biotronik.com |
| ID | Term |
|---|---|
| D009682 | Magnetic Resonance Spectroscopy |
| ID | Term |
|---|---|
| D013057 | Spectrum Analysis |
| D002623 | Chemistry Techniques, Analytical |
| D008919 | Investigative Techniques |
Not provided
Not provided
|
|
|
|